// App-Quantinova.ai

e17547 : Combinatorial expression of androgen receptor splice variants: No predictive value in castration-resistant prostate cancer patients treated with enzalutamide (enza) or abiraterone (abi).

Researchers

Presenter

  • Katrin Schlack

Principal Investigators

  • Konstantin Seitzer

  • Martin Boegemann

  • Laura-Maria Krabbe

  • Andres Jan Schrader

  • Norbert Grundmann

  • Dorothee Tiedje

  • Julie Steinestel

  • Christof Bernemann

Medical Centers

  • Department of Ophthalmology, University of Muenster Medical Center, Muenster, Germany

  • University of Muenster Medical Center, Munster, Germany

  • Department of Bioinformatics, University of Münster, Münster, Germany

  • Department of Urology, University of Magdeburg, Magdeburg, Germany

  • Department of Urology, University of Muenster, Munster, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Enzalutamide

  • CB-7598

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved